<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35581622</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1756-9966</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of experimental &amp; clinical cancer research : CR</Title>
          <ISOAbbreviation>J Exp Clin Cancer Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Correction: GPR119 agonist enhances gefitinib responsiveness through lactate-mediatedinhibition of autophagy.</ArticleTitle>
        <Pagination>
          <StartPage>176</StartPage>
          <MedlinePgn>176</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">176</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13046-022-02388-0</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Im</LastName>
            <ForeName>Ji Hye</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kang</LastName>
            <ForeName>Keon Wook</ForeName>
            <Initials>KW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nuclear Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Sun Young</ForeName>
            <Initials>SY</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy, Dankook University, Cheonan-si, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Yoon Gyoon</ForeName>
            <Initials>YG</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy, Dankook University, Cheonan-si, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>An</LastName>
            <ForeName>Yong Jin</ForeName>
            <Initials>YJ</Initials>
            <AffiliationInfo>
              <Affiliation>Natural Product Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Sunghyouk</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Natural Product Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jung</LastName>
            <ForeName>Byung Hwa</ForeName>
            <Initials>BH</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Recognition Research Center, Korea Institute of Science and Technology, Seoul, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Choi</LastName>
            <ForeName>Song-Yi</ForeName>
            <Initials>SY</Initials>
            <AffiliationInfo>
              <Affiliation>College of Medicine, Chungnam National University, Daejeon, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Jin-Sun</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>College of Medicine, Chungnam National University, Daejeon, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kang</LastName>
            <ForeName>Keon Wook</ForeName>
            <Initials>KW</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. kwkang@snu.ac.kr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016425">Published Erratum</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Exp Clin Cancer Res</MedlineTA>
        <NlmUniqueID>8308647</NlmUniqueID>
        <ISSNLinking>0392-9078</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumFor">
          <RefSource>J Exp Clin Cancer Res. 2018 Nov 29;37(1):295</RefSource>
          <PMID Version="1">30497501</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>23</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35581622</ArticleId>
        <ArticleId IdType="pmc">PMC9112569</ArticleId>
        <ArticleId IdType="doi">10.1186/s13046-022-02388-0</ArticleId>
        <ArticleId IdType="pii">10.1186/s13046-022-02388-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Im JH, Kang K, Kim SY, et al.  GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy. J Exp Clin Cancer Res. 2018;37:295. doi: 10.1186/s13046-018-0949-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13046-018-0949-2</ArticleId>
            <ArticleId IdType="pmc">PMC6267899</ArticleId>
            <ArticleId IdType="pubmed">30497501</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
